The Power List is our chance to put the pharmaceutical and drug development industry’s inspirational thought leaders, opinion shapers and unsung heroes in the spotlight. We’re relying on you to ensure that the breadth of perspectives is as wide as possible!
personalized, responsive service and to improve the site, we remember and store information about how you use
The Medicine Maker
Welcome to the December issue. Upfront explores Brexit and the UK’s current Withdrawal Agreement woes, transdermal patches for drug delivery, and the exploitation of CRISPR technology to modify embryonic genomes. Giovanni Appendino explains why we should tap into the medical potential of cannabis in “In My View,” while our cover feature highlights the most innovative technologies of the past year with our Innovation Awards. And Gavin Yamey discusses how a new financial modelling tool can help bridge the funding gap for neglected diseases in “Business.” In our latest Sitting Down With… Stanley Crooke, CEO at Ionis Pharmaceuticals argues that weathering the storm when creating new platforms can lead to positive outcomes.